Medical Marijuana I
Medical Marijuana, Inc., an investment holding company, operates in the cannabinoid-based nutraceutical industry. It engages in creating international CBD pipeline; produces legal cannabis products; develops cannabis drug and medication; supports services for cannabis industry; and develops market for medical cannabis. Medical Marijuana, Inc. was incorporated in 2005 and is based in Vista, Califo… Read more
Medical Marijuana I (MJNA) - Total Liabilities
Latest total liabilities as of March 2025: $17.60 Million USD
Based on the latest financial reports, Medical Marijuana I (MJNA) has total liabilities worth $17.60 Million USD as of March 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Medical Marijuana I - Total Liabilities Trend (2009–2024)
This chart illustrates how Medical Marijuana I's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Medical Marijuana I Competitors by Total Liabilities
The table below lists competitors of Medical Marijuana I ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Nova Mentis Life Science Corp
PINK:NMLSF
|
USA | $301.63K |
|
BR01
F:BR01
|
Germany | €376.68K |
|
Merchant House International Ltd
AU:MHI
|
Australia | AU$1.79 Million |
|
BioQuest Corp
PINK:BQST
|
USA | $988.95K |
|
SMIS Corporation Bhd
KLSE:7132
|
Malaysia | RM58.56 Million |
|
Bürgerliches Brauhaus Ravensburg - Lindau Aktiengesellschaft
STU:BBR
|
Germany | €1.79 Million |
Liability Composition Analysis (2009–2024)
This chart breaks down Medical Marijuana I's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.73 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.35 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Medical Marijuana I's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Medical Marijuana I (2009–2024)
The table below shows the annual total liabilities of Medical Marijuana I from 2009 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $18.03 Million | -8.14% |
| 2023-12-31 | $19.63 Million | +37.04% |
| 2022-12-31 | $14.32 Million | +23.66% |
| 2021-12-31 | $11.58 Million | -39.04% |
| 2020-12-31 | $19.00 Million | -18.34% |
| 2019-12-31 | $23.27 Million | -4.79% |
| 2018-12-31 | $24.44 Million | +58.17% |
| 2017-12-31 | $15.45 Million | +21.19% |
| 2016-12-31 | $12.75 Million | -15.14% |
| 2015-12-31 | $15.02 Million | -47.34% |
| 2014-12-31 | $28.53 Million | +1992.59% |
| 2013-12-31 | $1.36 Million | +1507.70% |
| 2012-12-31 | $84.80K | -57.84% |
| 2010-12-31 | $201.15K | +553.96% |
| 2009-12-31 | $30.76K | -- |